George Weissgerber

George Weissgerber

Company: PulseSight Therapeutics

Job title: Chief Medical Officer

Seminars:

A Novel Approach to Protect Photoreceptors and RPE Integrity to Slow Geographic Atrophy Progression 4:30 pm

Exploring the emerging role of ferroptosis — an iron-dependent, lipid peroxidation-driven form of programmed cell death in retinal pigment epithelium (RPE) dysfunction and photoreceptor degeneration in dry AMD Discussing how oxidative stress, iron accumulation, and impaired lipid metabolism converge to trigger ferroptotic pathways in the aging retina Presenting early Phase I trial results for PST-611, a novel gene…Read more

day: Day1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.